This document is about Ipilimumab, an immunotherapy drug used to treat advanced melanoma.
This Spanish-language patient guide for Ipilimumab explains what the treatment is, how the medicine works with the immune system, and which signs and symptoms may appear during or after treatment. It describes the checks the doctor performs before starting treatment and lists possible side effects by body area, including intestinal and stomach, eye, liver, nervous system, skin and general effects.
The guide also covers other important adverse events such as complications after an allogeneic stem cell transplant and infusion reactions, and it includes a Patient Alert Card that the patient should carry at all times, with space for the prescribing doctor's contact details. Free telephone numbers for BMS Medical Information in several Latin American countries are listed. This manual is written in Spanish.
| Active substance | A protein that helps the immune system attack and destroy cancer cells |
|---|---|
| Timing of infusion reactions | Usually during or within 24 hours of receiving the dose |
Ipilimumab contains a protein as its active substance, which helps the immune system's T lymphocytes fight cancer cells.
They can occur at any time during treatment or even months after treatment has ended.
Call your doctor immediately if you have any sign or symptom, or if they persist or worsen, and do not treat them on your own.
It reminds you of symptoms you should report right away to your doctor or nurse and lets other doctors know you are being treated with Ipilimumab.